[1] GestationalTrophoblastic, 2010.Neoplasia,RCOG Green-top Guideline No. 38 -
[2] SecklM,SebireN,FisherR,GolfierF,MassugerL,SessaC, 2013.Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up,Ann Oncol 24 vi39 -vi50
[3] BrownJR. Naumann,W , Seckl,MJ , Schink,J., 2017.15 years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage,Gynecologic Oncology 144 200 -07
[4] AzizN,YousfaniS,SoomroI,MumtazFJ, 2012.Gestational trophoblastic disease,Ayub Med Coll Abbottabad 24 7 -9
[5] AlmasiA,AlmassinokianiF, 2014.Frequency of molar pregnancies in health care centers of Tehran, Iran,J Reprod Infertil 15 157 -60
[6] NganHYS,SecklMJ,BerkowitzRS, 2015.Update on the diagnosis and management of gestational trophoblastic disease,Int J Gynaecol Obstet 131 S123 -S126
[7] RoyJ,WasikS,BegumA,HossenM, 2011.Metastatic choriocarcinoma following live birth - A rare presentation,Bangabandhu Sheikh Mujib Med Univ j 4 116 -8
[8] RachidBezad, 2017.8. Implementation and Monitoring of a Gestational Trophoblastic Disease Management Program in a Tertiary Hospital in Morocco: Opportunities and Challenges,Int J Gynaecol Obstet 5093472 8 -
[9] VitthalraoS,AherV,GadhiyaS,SunilS., 2017.Gestational trophoblastic disease - Clinicopathological study at tertiary care hospital,J Clin Diagn Res 11 EC27 -EC30